fluxd.news

Anavex Life Lead Drug Targets Early Alzheimer's Cause - New Study Highlights · fluxd.news

LIVE

Fintech

Anavex Life Lead Drug Targets Early Alzheimer's Cause - New Study Highlights

Benzinga·March 20, 2026 at 12:04 PM

New study links early brain cleanup failure to Alzheimer's, supporting Anavex Life drug approach targeting disease before plaques form.

Original Source

Benzinga — www.benzinga.com

Related in Fintech

OpenAI, Google refine AI commerce strategies
PYMNTS
Nevada bars Kalshi from offering event contracts
PYMNTS
Federal Reserve orders SVB collapse review
PYMNTS
Centralizing Treasury Operations Offers Key Benefits
PYMNTS